GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (STU:DU8) » Definitions » E10

Genetic Technologies (STU:DU8) E10 : €0.00 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Genetic Technologies E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Genetic Technologies's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was -2.70% per year. During the past 5 years, the average E10 Growth Rate was -11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Genetic Technologies was 0.40% per year. The lowest was -25.80% per year. And the median was -13.65% per year.

As of today (2024-05-24), Genetic Technologies's current stock price is €0.066. Genetic Technologies's E10 for the quarter that ended in Dec. 2023 was €0.00. Genetic Technologies's Shiller PE Ratio of today is .


Genetic Technologies E10 Historical Data

The historical data trend for Genetic Technologies's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies E10 Chart

Genetic Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.82 -5.10 -2.99 -1.69 -1.11

Genetic Technologies Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.11 - - -

Competitive Comparison of Genetic Technologies's E10

For the Diagnostics & Research subindustry, Genetic Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetic Technologies's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genetic Technologies's Shiller PE Ratio falls into.



Genetic Technologies E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genetic Technologies's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/126.3989*126.3989
=0.000

Current CPI (Dec. 2023) = 126.3989.

Genetic Technologies Quarterly Data

per share eps CPI Adj_EPS
200812 -0.418 85.814 -0.616
200906 -0.642 86.278 -0.941
200912 -0.635 87.578 -0.916
201006 -0.887 88.971 -1.260
201012 0.771 89.993 1.083
201106 -0.605 92.129 -0.830
201112 -0.574 92.686 -0.783
201203 0.000 92.779 0.000
201206 -0.260 93.244 -0.352
201212 -0.595 94.730 -0.794
201303 0.000 95.101 0.000
201306 -0.782 95.473 -1.035
201312 -0.618 97.330 -0.803
201406 -0.482 98.352 -0.619
201412 -0.425 99.002 -0.543
201506 -0.149 99.838 -0.189
201512 -0.155 100.673 -0.195
201606 -0.148 100.859 -0.185
201612 -0.143 102.159 -0.177
201706 -0.113 102.809 -0.139
201712 -0.084 104.110 -0.102
201806 -0.057 104.945 -0.069
201812 -0.076 105.967 -0.091
201906 -14.676 106.617 -17.399
201912 -0.050 107.917 -0.059
202006 -0.043 106.246 -0.051
202009 0.000 107.917 0.000
202012 -0.031 108.846 -0.036
202103 0.000 109.496 0.000
202106 -0.019 110.332 -0.022
202109 0.000 111.168 0.000
202112 -0.025 112.654 -0.028
202203 0.000 115.069 0.000
202206 -0.027 117.112 -0.029
202209 0.000 119.248 0.000
202212 -0.038 121.477 -0.040
202303 0.000 123.148 0.000
202306 0.030 124.170 0.031
202309 0.000 125.656 0.000
202312 0.000 126.399 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Genetic Technologies  (STU:DU8) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Genetic Technologies E10 Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetic Technologies (STU:DU8) Business Description

Traded in Other Exchanges
Address
60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Genetic Technologies (STU:DU8) Headlines

No Headlines